heart disease

Atypical myocardial infarction

Atypical myocardial infarction

While Jane*, a 47-year-old woman with no significant medical history, visits her neighbor, Helen, in the hospital, Helen notes that Jane appears pale. Jane says that she hasn’t…

FDA approves treatment for two rare diseases

On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than 17 years of age. On the…
United States Food and Drug

FDA expands use of artificial heart valve

Expanded use approval relies on real world evidence The U.S. Food and Drug Administration today approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for…

Make your health a priority.

May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.

Study: Fatigue common in CHD

A study in Nursing Research found that 40% of patients with stable coronary heart disease (CHD) reported fatigue more than 3 days a week lasting more than one…
cardiovascular disease heart walking problem elder

Walking problems and cardiovascular disease risk

The more risk factors for cardiovascular disease people aged 60-78 have, the faster walking speed declines, according to a study in the Journal of American Geriatrics Society. (more…)

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Take the 2024 Nursing Trends and Salary Survey, available now through November 1st 2024

See Past Results
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary purpose of a 3-minute foot assessment in patients with comorbidities such as diabetes or peripheral arterial disease?